SBC Medical Group Holdings Inc. Files 8-K
Ticker: SBCWW · Form: 8-K · Filed: Dec 31, 2025 · CIK: 1930313
Sentiment: neutral
Topics: corporate-filing, 8-K, financial-reporting
TL;DR
SBC Medical Group Holdings filed an 8-K on 12/31/25 covering various corporate events and financials.
AI Summary
SBC Medical Group Holdings Inc. filed an 8-K on December 31, 2025, reporting on events including Regulation FD disclosures, other events, and financial statements. The company, formerly known as Pono Capital Two, Inc., is incorporated in Delaware and headquartered in Irvine, California.
Why It Matters
This filing provides an update on the company's corporate activities and financial reporting, which is crucial for investors to understand its current status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Players & Entities
- SBC Medical Group Holdings Inc (company) — Registrant
- Pono Capital Two, Inc. (company) — Former company name
- December 31, 2025 (date) — Date of earliest event reported
- Irvine, CA (location) — Business address city and state
FAQ
What is the primary purpose of this 8-K filing?
The 8-K filing reports on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of December 31, 2025.
What was SBC Medical Group Holdings Inc. formerly known as?
SBC Medical Group Holdings Inc. was formerly known as Pono Capital Two, Inc.
In which state is SBC Medical Group Holdings Inc. incorporated?
SBC Medical Group Holdings Inc. is incorporated in Delaware.
What is the business address of SBC Medical Group Holdings Inc.?
The business address is 200 Spectrum Center Dr., Suite 300, Irvine, CA 92618.
What is the fiscal year end for SBC Medical Group Holdings Inc.?
The fiscal year end for SBC Medical Group Holdings Inc. is December 31.
Filing Stats: 758 words · 3 min read · ~3 pages · Grade level 12 · Accepted 2025-12-31 06:39:31
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share SBC The Nasdaq
- $11.50 — of Common Stock at an exercise price of $11.50 per share SBCWW The Nasdaq Stock Ma
- $20.0 million — egistration statement on Form S-3 and a $20.0 million share repurchase program, as described
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex99-1.htm (EX-99.1) — 15KB
- 0001493152-25-029699.txt ( ) — 272KB
- sbc-20251231.xsd (EX-101.SCH) — 4KB
- sbc-20251231_def.xml (EX-101.DEF) — 26KB
- sbc-20251231_lab.xml (EX-101.LAB) — 36KB
- sbc-20251231_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SBC Medical Group Holdings Incorporated Date: December 31, 2025 By: /s/ Yuya Yoshida Name: Yuya Yoshida Title: Chief Financial Officer